Shanrong Biotechnology Corp.
SRBT
$0.3216
-$0.3284-50.52%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -295.70% | 134.62% | -6.52% | -0.78% | -21.57% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8,038.01% | 100.00% | -100.00% | -67.18% | -92.60% |
| Change in Net Operating Assets | -38.37% | -470.72% | 14.31% | 214.08% | 1,835.41% |
| Cash from Operations | 12.78% | 70.97% | -49.56% | 75.89% | -55.15% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.84% | -- | -- | -- | -- |
| Cash from Investing | -39.13% | -- | -- | -- | -- |
| Total Debt Issued | -102.49% | -63.27% | -84.34% | -97.78% | -23.49% |
| Total Debt Repaid | 93.66% | -121.49% | 87.93% | 93.16% | -43.72% |
| Issuance of Common Stock | 24.19% | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -0.64% | -75.11% | -76.04% | -47.60% | 34.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.55% | -104.34% | -1,118.44% | 804.02% | -233.73% |
